Income Statement Neurizon Therapeutics Limited

Stocks

NUZ

AU0000357261

Pharmaceuticals

Market Closed - Australian S.E. Other stock markets 12:37:35 11/06/2026 HKT			5-day change	1st Jan Change
0.0600 ^AUD	-1.64%		-3.23%	-29.41%

05-27	Neurizon Therapeutics Limited Expands Regimen I of the Healey Als Platform Trial to 240 Participants	CI
05-13	Neurizon Therapeutics receives ethics approval for Phase 1 Nuz-001 oral liquid formulation study	RE

226dd8e0e6.KT6BBaHf13zKRNuSRznyqNWh0L_aXmxY5ms4cSyiFgU.HVbsSpHo4wmNKI_EcBS5nIXEvM2IKBwyrSwBB23XfFNgUKxI8IaWP499uA

Published financial data: NEURIZON THERAPEUTICS LIMITED

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: June	2021	2022	2023	2024	2025
Revenues	2.14M	3.38M	2.82M	-	-
Other Revenues, Total	1.52M	1.13M	995K	842K	1.54M
Total Revenues	3.66M	4.51M	3.82M	842K	1.54M
Cost of Goods Sold, Total	225K	314K	1.34M	-	-
Gross Profit	3.43M	4.2M	2.48M	842K	1.54M
Selling General & Admin Expenses, Total	3.85M	4.74M	4.3M	2.44M	6.28M
Provision for Bad Debts	-	-	77.98K	-	-
Stock-Based Compensation (IS)	-	-	-	369K	518K
R&D Expenses	554K	759K	1.03M	3.85M	11.68M
Depreciation & Amortization - (IS)	298K	315K	327K	1.64K	44
Other Operating Expenses, Total	4.7M	5.82M	5.74M	6.66M	18.48M
Operating Income	-1.27M	-1.62M	-3.25M	-5.82M	-16.94M
Interest Expense, Total	-78.99K	-88.51K	-81.86K	-	-
Interest And Investment Income	14.72K	536	81.02K	24.47K	344K
Net Interest Expenses	-64.27K	-87.98K	-837	24.47K	344K
EBT, Excl. Unusual Items	-1.34M	-1.71M	-3.25M	-5.79M	-16.59M
Asset Writedown	-	-	-2.96M	-3.11M	-
EBT, Incl. Unusual Items	-1.34M	-1.71M	-6.21M	-8.9M	-16.59M
Earnings From Continuing Operations	-1.34M	-1.71M	-6.21M	-8.9M	-16.59M
Earnings Of Discontinued Operations	-	-	-	1.23M	-
Net Income to Company	-1.34M	-1.71M	-6.21M	-7.67M	-16.59M
Net Income - (IS)	-1.34M	-1.71M	-6.21M	-7.67M	-16.59M
Net Income to Common Incl Extra Items	-1.34M	-1.71M	-6.21M	-7.67M	-16.59M
Net Income to Common Excl. Extra Items	-1.34M	-1.71M	-6.21M	-8.9M	-16.59M
Per Share Items
Net EPS - Basic	-0	-0.01	-0.02	-0.02	-0.03
Basic EPS - Continuing Operations	-0	-0.01	-0.02	-0.02	-0.03
Basic Weighted Average Shares Outstanding	316M	317M	321M	371M	487M
Net EPS - Diluted	-0	-0.01	-0.02	-0.02	-0.03
Diluted EPS - Continuing Operations	-0	-0.01	-0.02	-0.02	-0.03
Diluted Weighted Average Shares Outstanding	316M	317M	321M	371M	487M
Normalized Basic EPS	-0	-0	-0.01	-0.01	-0.02
Normalized Diluted EPS	-0	-0	-0.01	-0.01	-0.02
Supplemental Items
EBITDA	-1.11M	-1.45M	-3.08M	-5.82M	-16.94M
EBITA	-1.27M	-1.62M	-3.25M	-5.82M	-16.94M
EBIT	-1.27M	-1.62M	-3.25M	-5.82M	-16.94M
Total Revenues (As Reported)	3.67M	4.51M	3.9M	-	-
Normalized Net Income	-836K	-1.07M	-2.03M	-3.62M	-10.37M
Supplemental Operating Expense Items
General and Administrative Expenses	1.46M	1.77M	1.66M	1.7M	4.57M
Research And Development Expense From Footnotes	554K	759K	1.03M	3.85M	11.68M
Stock-Based Comp., SG&A Exp. (Total)	155K	-46.34K	-10K	-	-
Stock-Based Comp., Other (Total)	-	-	-	369K	518K
Total Stock-Based Compensation	155K	-46.34K	-10K	369K	518K

Fiscal Period: June	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	3.02M	2.42M	2.71M	9.71M	4.16M
Short Term Investments	4.22K	4.22K	15.78K	1.02M	20K
Trading Asset Securities, Total	-	-	-	-	-
Total Cash And Short Term Investments	3.02M	2.42M	2.72M	10.73M	4.18M
Accounts Receivable, Total	242K	185K	148K	18.49K	-
Other Receivables	-	-	-	-	-
Total Receivables	242K	185K	148K	18.49K	-
Inventory	1.01M	1.04M	0	-	-
Prepaid Expenses	62.54K	63.67K	85.69K	249K	97.49K
Other Current Assets, Total	19.58K	18.99K	65.59K	128K	78.66K
Total Current Assets	4.36M	3.73M	3.02M	11.12M	4.36M
Gross Property Plant And Equipment	5.06M	5.11M	2.21M	-	-
Accumulated Depreciation	-1.61M	-1.88M	-2.21M	-	-
Net Property Plant And Equipment	3.45M	3.24M	1.64K	-	1.5K
Other Intangibles, Total	3.14M	3.11M	3.11M	-	-
Other Long-Term Assets, Total	-	-	-	-	-
Total Assets	10.95M	10.08M	6.13M	11.12M	4.36M
Liabilities
Accounts Payable, Total	559K	604K	926K	827K	-
Accrued Expenses, Total	206K	214K	263K	34.08K	209K
Short-term Borrowings	-	210K	-	-	-
Current Portion of Long-Term Debt	38.21K	-	-	-	-
Current Portion of Leases	108K	138K	158K	-	-
Other Current Liabilities	-	-	-	35K	1.32M
Total Current Liabilities	911K	1.17M	1.35M	896K	1.53M
Long-Term Debt	-	-	-	-	-
Long-Term Leases	1.13M	1.04M	891K	-	-
Pension & Other Post Retirement Benefits	30.38K	31.02K	3.34K	649	4.97K
Other Non Current Liabilities	-	-	-	-	-
Total Liabilities	2.07M	2.23M	2.24M	897K	1.54M
Common Stock, Total	55.33M	55.34M	57.63M	69.94M	78.8M
Retained Earnings	-48.54M	-50.25M	-56.46M	-64.13M	-77.98M
Comprehensive Income and Other	2.09M	2.75M	2.72M	4.42M	2M
Total Common Equity	8.88M	7.84M	3.89M	10.23M	2.82M
Total Equity	8.88M	7.84M	3.89M	10.23M	2.82M
Total Liabilities And Equity	10.95M	10.08M	6.13M	11.12M	4.36M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	317M	317M	349M	486M	492M
ECS Total Common Shares Outstanding	317M	317M	347M	445M	492M
Book Value / Share	0.03	0.02	0.01	0.02	0.01
Tangible Book Value	5.74M	4.73M	782K	10.23M	2.82M
Tangible Book Value Per Share	0.02	0.01	0	0.02	0.01
Total Debt	1.28M	1.39M	1.05M	0	0
Net Debt	-1.75M	-1.03M	-1.67M	-10.73M	-4.18M
Account Code - Inventory Valuation	5	5	5	-	3
Inventories - Raw Materials, Total	10.57K	10.57K	4.36K	-	-
Inventories - Work In Process, Total	52.88K	59.04K	-	-	-
Inventories - Finished Goods, Total	945K	973K	1.05M	-	-
Machinery, Total	3.64M	3.63M	1.65M	-	-
Accumulated Allowance for Doubtful Accounts (Supple)	-	-	77.98K	-	-

Fiscal Period: June	2021	2022	2023	2024	2025
Net Income	-1.34M	-1.71M	-6.21M	-7.67M	-16.59M
Depreciation & Amortization - CF	298K	315K	327K	1.64K	44
Depreciation & Amortization, Total	298K	315K	327K	1.64K	44
(Gain) Loss From Sale Of Asset	-	-	180	-1.23M	-
Asset Writedown & Restructuring Costs	-	32.52K	3.58M	3.11M	-
Stock-Based Compensation (CF)	155K	-46.34K	-10K	369K	518K
Other Operating Activities, Total	45.89K	-	506K	-	-
Change In Accounts Receivable	55.73K	56.63K	-40.9K	139K	16.99K
Change In Inventories	-151K	-34.92K	-4.22K	-	-
Change In Accounts Payable	2.01K	44.63K	322K	528K	485K
Change in Other Net Operating Assets	-7.06K	8.5K	-36.68K	-414K	1.28M
Cash from Operations	-938K	-1.33M	-1.56M	-5.17M	-14.29M
Capital Expenditure	-102K	-43.38K	-34.76K	-	-1.54K
Divestitures	-	-	-	-165K	-
Sale (Purchase) of Intangible assets	-36.32K	-	-167	-	-
Investment in Marketable and Equity Securities, Total	-	-	-	-1M	-20K
Cash from Investing	-138K	-43.38K	-34.93K	-1.17M	-21.54K
Long-Term Debt Issued, Total	-	210K	-	-	-
Total Debt Issued	-	210K	-	-	-
Long-Term Debt Repaid, Total	-321K	-158K	-354K	-	-
Total Debt Repaid	-321K	-158K	-354K	-	-
Issuance of Common Stock	1.58M	718K	2.4M	12.91M	8.8M
Other Financing Activities, Total	-44.99K	-	-156K	431K	-35K
Cash from Financing	1.22M	771K	1.89M	13.34M	8.76M
Net Change in Cash	140K	-605K	290K	7.01M	-5.55M
Supplemental Items
Cash Interest Paid	33.1K	88.51K	81.86K	-	-
Levered Free Cash Flow	-616K	-769K	-421K	-3.65M	-9.21M
Unlevered Free Cash Flow	-566K	-713K	-369K	-3.65M	-9.21M
Change In Net Working Capital	85.76K	-74.19K	-1.38M	388K	-856K
Net Debt Issued / Repaid	-321K	52.49K	-354K	-	-

Fiscal Period: June	2021	2022	2023	2024	2025
Profitability
Return on Assets	-7.33	-9.63	-25.09	-42.14	-136.74
Return on Total Capital	-7.89	-10.45	-28.71	-47.94	-162.25
Return On Equity %	-15.37	-20.43	-105.88	-126.08	-254.33
Return on Common Equity	-15.37	-20.43	-105.88	-126.08	-254.33
Margin Analysis
Gross Profit Margin %	93.84	93.03	65.02	100	100
SG&A Margin	105.34	105.15	112.61	290	408.37
EBITDA Margin %	-30.33	-32.22	-80.68	-690.89	-1.1K
EBITA Margin %	-34.81	-35.92	-85.19	-691.08	-1.1K
EBIT Margin %	-34.81	-35.92	-85.19	-691.08	-1.1K
Income From Continuing Operations Margin %	-36.57	-37.87	-162.64	-1.06K	-1.08K
Net Income Margin %	-36.57	-37.87	-162.64	-911.61	-1.08K
Net Avail. For Common Margin %	-36.57	-37.87	-162.64	-1.06K	-1.08K
Normalized Net Income Margin	-22.86	-23.67	-53.26	-430.11	-674.39
Levered Free Cash Flow Margin	-16.83	-17.04	-11.01	-434.01	-599.16
Unlevered Free Cash Flow Margin	-15.48	-15.81	-9.67	-434.01	-599.16
Asset Turnover
Asset Turnover	0.34	0.43	0.47	0.1	0.2
Fixed Assets Turnover	1.04	1.35	2.36	-	-
Receivables Turnover (Average Receivables)	7.93	15.83	16.93	-	-
Inventory Turnover (Average Inventory)	0.24	0.31	2.56	-	-
Short Term Liquidity
Current Ratio	4.78	3.2	2.24	12.42	2.84
Quick Ratio	3.58	2.23	2.13	12	2.73
Operating Cash Flow to Current Liabilities	-1.03	-1.14	-1.16	-5.77	-9.32
Days Sales Outstanding (Average Receivables)	46.01	23.06	21.56	-	-
Days Outstanding Inventory (Average Inventory)	1.51K	1.19K	142.47	-	-
Average Days Payable Outstanding	541.94	607.51	-	-	-
Cash Conversion Cycle (Average Days)	1.02K	606.34	-	-	-
Long Term Solvency
Total Debt/Equity	14.39	17.66	26.97	-	-
Total Debt / Total Capital	12.58	15.01	21.24	-	-
LT Debt/Equity	12.74	13.22	22.9	-	-
Long-Term Debt / Total Capital	11.14	11.24	18.03	-	-
Total Liabilities / Total Assets	18.93	22.16	36.56	8.06	35.29
EBIT / Interest Expense	-16.12	-18.31	-39.75	-	-
EBITDA / Interest Expense	-12.34	-14.75	-35.76	-	-
(EBITDA - Capex) / Interest Expense	-13.63	-15.24	-36.18	-	-
Total Debt / EBITDA	-1.31	-1.06	-0.36	-	-
Net Debt / EBITDA	1.79	0.79	0.57	1.85	0.25
Total Debt / (EBITDA - Capex)	-1.19	-1.03	-0.35	-	-
Net Debt / (EBITDA - Capex)	1.62	0.77	0.56	1.85	0.25
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-11.24	23.33	-15.32	-3.66	82.7
Gross Profit, 1 Yr. Growth %	-11.42	22.27	-40.82	-3.66	82.7
EBITDA, 1 Yr. Growth %	1.35	31.02	112.04	340.04	191.26
EBITA, 1 Yr. Growth %	2.11	27.27	100.82	252.95	191.18
EBIT, 1 Yr. Growth %	2.11	27.27	100.82	252.95	191.18
Earnings From Cont. Operations, 1 Yr. Growth %	-1.81	27.73	263.63	466.09	86.45
Net Income, 1 Yr. Growth %	-1.81	27.73	263.63	23.53	116.26
Normalized Net Income, 1 Yr. Growth %	-1.81	27.73	90.53	268.44	186.47
Diluted EPS Before Extra, 1 Yr. Growth %	-7.93	27.27	259	389.92	41.85
Accounts Receivable, 1 Yr. Growth %	-18.72	-23.4	-20.01	-87.52	-
Inventory, 1 Yr. Growth %	17.55	3.46	-100	-	-
Net Property, Plant and Equip., 1 Yr. Growth %	-3.19	-6.28	-99.95	-	-
Total Assets, 1 Yr. Growth %	1.93	-7.99	-39.17	81.47	-60.82
Tangible Book Value, 1 Yr. Growth %	5.9	-17.49	-83.49	1.21K	-72.42
Common Equity, 1 Yr. Growth %	4.15	-11.67	-50.42	163	-72.42
Cash From Operations, 1 Yr. Growth %	-26.14	42.04	17.41	230.43	176.53
Capital Expenditures, 1 Yr. Growth %	236.49	-57.35	-19.86	-	-
Levered Free Cash Flow, 1 Yr. Growth %	-31.3	24.86	-45.28	-676.04	152.22
Unlevered Free Cash Flow, 1 Yr. Growth %	-31.12	25.98	-48.21	-676.04	152.22
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-8.28	4.63	2.2	-56.8	32.67
Gross Profit, 2 Yr. CAGR %	-7.53	4.07	-14.93	-55.21	32.67
EBITDA, 2 Yr. CAGR %	-9.32	15.23	66.68	100.05	258
EBITA, 2 Yr. CAGR %	-8.52	14	59.87	89.48	220.58
EBIT, 2 Yr. CAGR %	-8.52	14	59.87	89.48	220.58
Earnings From Cont. Operations, 2 Yr. CAGR %	-7.15	11.99	115.52	128.26	224.88
Net Income, 2 Yr. CAGR %	-7.15	11.99	115.52	111.94	63.44
Normalized Net Income, 2 Yr. CAGR %	-7.15	11.99	56	84.15	224.88
Diluted EPS Before Extra, 2 Yr. CAGR %	-22.62	8.25	113.75	111.02	163.62
Accounts Receivable, 2 Yr. CAGR %	-3.32	-21.1	-21.73	-68.41	-
Inventory, 2 Yr. CAGR %	28.36	10.28	-	-	-
Net Property, Plant and Equip., 2 Yr. CAGR %	18.31	-4.75	-97.82	-	-4.36
Total Assets, 2 Yr. CAGR %	12.89	-3.16	-25.19	5.06	-15.68
Tangible Book Value, 2 Yr. CAGR %	14.88	-6.52	-63.09	46.98	89.96
Common Equity, 2 Yr. CAGR %	9.14	-4.08	-33.82	14.19	-14.84
Cash From Operations, 2 Yr. CAGR %	-22.31	2.42	29.14	96.97	202.28
Capital Expenditures, 2 Yr. CAGR %	-16.74	19.79	-41.54	-	-78.92
Levered Free Cash Flow, 2 Yr. CAGR %	-26.62	-7.39	-17.34	118.02	281.17
Unlevered Free Cash Flow, 2 Yr. CAGR %	-28.68	-6.85	-19.23	126.31	281.17
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	3.91	1.24	-2.5	-38.72	-30.14
Gross Profit, 3 Yr. CAGR %	4.94	1.5	-13.78	-37.4	-28.44
EBITDA, 3 Yr. CAGR %	-22.81	2.52	41.21	73.72	126.73
EBITA, 3 Yr. CAGR %	-20.46	2.12	37.68	65.94	118.66
EBIT, 3 Yr. CAGR %	-20.46	2.12	37.68	65.94	118.66
Earnings From Cont. Operations, 3 Yr. CAGR %	-19.06	3.27	65.83	88.1	113.37
Net Income, 3 Yr. CAGR %	-19.06	3.27	65.83	79.03	113.37
Normalized Net Income, 3 Yr. CAGR %	-19.06	3.27	33.69	63.01	113.37
Diluted EPS Before Extra, 3 Yr. CAGR %	-37.33	-8.66	61.43	78.29	84.85
Accounts Receivable, 3 Yr. CAGR %	-0.87	-10.54	-20.74	-57.56	-
Inventory, 3 Yr. CAGR %	20.65	19.46	-	-	-
Net Property, Plant and Equip., 3 Yr. CAGR %	11.47	9.47	-92.29	-	-92.26
Total Assets, 3 Yr. CAGR %	9.43	5.45	-17.06	0.52	-24.38
Tangible Book Value, 3 Yr. CAGR %	12.5	2.88	-47.56	21.25	-15.86
Common Equity, 3 Yr. CAGR %	7.55	1.71	-23.02	4.82	-28.89
Cash From Operations, 3 Yr. CAGR %	-15.43	-5	7.19	76.63	120.55
Capital Expenditures, 3 Yr. CAGR %	-51.08	-33.38	4.77	-	-67.1
Levered Free Cash Flow, 3 Yr. CAGR %	-25.32	-12.39	-22.29	81.05	128.87
Unlevered Free Cash Flow, 3 Yr. CAGR %	-27.08	-13.79	-23.4	86.17	134.64
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	6.11	6.4	3.22	-27.99	-17.89
Gross Profit, 5 Yr. CAGR %	6.68	7.18	-3.51	-26.83	-16.87
EBITDA, 5 Yr. CAGR %	-8.65	4.13	5.02	33.94	72.96
EBITA, 5 Yr. CAGR %	-7.23	4.34	5.16	30.77	68.51
EBIT, 5 Yr. CAGR %	-7.23	4.34	5.16	30.77	68.51
Earnings From Cont. Operations, 5 Yr. CAGR %	-19.38	4.92	19.76	41.82	64.87
Net Income, 5 Yr. CAGR %	-19.38	4.92	19.76	37.68	64.87
Normalized Net Income, 5 Yr. CAGR %	-6.34	4.92	5.24	30.15	64.87
Diluted EPS Before Extra, 5 Yr. CAGR %	-36.94	-12.95	2.38	27.68	49.23
Accounts Receivable, 5 Yr. CAGR %	20.81	-3.56	-9.81	-41.01	-
Inventory, 5 Yr. CAGR %	25.65	16.46	-	-	-
Net Property, Plant and Equip., 5 Yr. CAGR %	13.68	13.18	-76.91	-	-78.88
Total Assets, 5 Yr. CAGR %	11.85	4.22	-6.01	5.29	-16.51
Tangible Book Value, 5 Yr. CAGR %	24.53	4.46	-27.97	18.66	-12.24
Common Equity, 5 Yr. CAGR %	12.07	2.55	-11.44	6.53	-19.85
Cash From Operations, 5 Yr. CAGR %	-10.13	1.19	0.17	27.17	62.28
Capital Expenditures, 5 Yr. CAGR %	-41.62	-5.32	-47.47	-	-44.83
Levered Free Cash Flow, 5 Yr. CAGR %	-25.31	-1.6	-22.23	26.16	59.38
Unlevered Free Cash Flow, 5 Yr. CAGR %	-26.41	-2.17	-24.04	26.83	62.15